Bortezomib will boost the level or outcome of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Greater flibanserin adverse consequences may perhaps happen if coadministered with several weak CYP3A4 inhibitors. levoketoconazole will raise the level or influence of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use https://mls00054446094937.elbloglibre.com/26705025/how-urolithin-a-can-save-you-time-stress-and-money